Cholesterol Ester Transfer Protein, Characterization of Monoclonal Antibodies against the Human Antigen

  • Y. L. Marcel
  • R. W. Milne
  • P. K. Weech
  • H. Czarnecka
  • C. B. Hesler
  • A. R. Tall
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 243)


Early work by Rehnborg and Nichols (1) showed that upon incubation of normolipemic plasma, cholesteryl ester (CE) concentration increased in VLDL, LDL and HDL whereas triglycerides (TG) concentration decreased in VLDL and increased in LDL and HDL. These experiments (1,2) were the first to document CE transfer between lipoproteins but the concept was really developed with the demonstration by Zilversmit et al (3) that the d > 1.21 g/ml fraction contained a protein that catalysed CE transfer between lipoproteins, a protein which is now identified as cholesterolester transfer protein (CETP) and which transfers CE and TG between lipoproteins.


Cholesteryl Ester Reverse Cholesterol Transport Cholesterol Ester Transfer Protein Cholesterol Ester Transfer Protein Activity Cholesteryl Ester Transfer Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rehnborg C.S. and Nichols A.V.(1964) Biochim. Biophys. Acta 84,596–603.PubMedGoogle Scholar
  2. 2.
    Nichols A.V. and Smith L.(1965)J. Lipid Res. 6,206–210.PubMedGoogle Scholar
  3. 3.
    Zilversmit D.B., Hughes L.B. and Balmer J.(1975) Biochim. Biophys. Acta A09,393–398.Google Scholar
  4. 4.
    Morton R.E. and Zilversmit D.B.(1982)J. Lipid Res. 23, 1058–1067.PubMedGoogle Scholar
  5. 5.
    Ihm I, Ellsworth J.L., Chataing B. and Harmony J.A.K (1982) J. Biol. Chem. 257,4818–4827.PubMedGoogle Scholar
  6. 6.
    Albers J.J., Tollefson J.H., Chen C. and Steinmetz A.(1984)Arteriosclerosis 4,9–58.Google Scholar
  7. 7.
    Tall A.R., Abreu E. and Shuman J.(1983) J. Biol. Chem. 258,2174–2180.PubMedGoogle Scholar
  8. 8.
    Hesler C.B., Swenson T.L., and Tall A.R.(1987) J. Biol. Chem. 262,2275–2282.PubMedGoogle Scholar
  9. 9.
    Jarnagin A.S., Kohr W. and Fielding C.J.(1987) Proc, Natl. Acad. Sci. USA 84,1854–1857.CrossRefGoogle Scholar
  10. 10.
    Busch S.J., Stuart W.D., Hug B.,Mao S.J.T. and Harmony J.A.K.(1987) J. Biol. Chem. 262,17563–17571.PubMedGoogle Scholar
  11. 11.
    Drayna D., Jarnagin A.S., McLean J., Henzel W., Kohr W., Fielding C.J. and Lawn R.(1987)Nature 327,632–634.PubMedCrossRefGoogle Scholar
  12. 12.
    Swanson T.L., Simmons J.S., Hesler C.B., Bisgaier C. and A.R. Tall.(1987) J. Biol. Chem. 262,16271–16274.Google Scholar
  13. 13.
    Morton R.E. and Zilversmit(1983) J. Biol. Chem. 258,11751–11757.PubMedGoogle Scholar
  14. 14.
    Sniderman A., Teng B., Vezina C. and Marcel Y.L.(1978) Atherosclerosis 31.,327–333.PubMedCrossRefGoogle Scholar
  15. 15.
    Barter P.J. and Jones M.E.(1979)Atherosclerosis 34,67–74.PubMedCrossRefGoogle Scholar
  16. 16.
    Marcel Y.L., Vezina C., Teng B. and Sniderman A.(1980)Atherosclerosis. 35,127–133.PubMedCrossRefGoogle Scholar
  17. 17.
    Hopkins G.J. and Barter P.J.(1980)Metabolism 29,546–550.PubMedCrossRefGoogle Scholar
  18. 18.
    Barter P.J., Gorjatschko L. and Calvert G.D.(1980) Biochim. Biophys. Acta 619,436–439.PubMedGoogle Scholar
  19. 19.
    Deckelbaum R.J., Eisenberg S., Oschry Y., Butbul E., Sharon I. and Olivecrona T.(1982) J. Biol. Chem. 257,6509–6517.PubMedGoogle Scholar
  20. 20.
    Noel S.P., Dupras R, Vezina C. and Marcel Y.L.(1984) Biochim. Biophys. Acta 796,277–284.PubMedGoogle Scholar
  21. 21.
    Eisenberg S.(1985)J. Lipid Res. 26,487–494.PubMedGoogle Scholar
  22. 22.
    Glomset J.A., Norum K.R. and King W.(1970) J. Clin. Invest. 49,1827–1837.PubMedCrossRefGoogle Scholar
  23. 23.
    Fielding C.J. and Fielding P.E.(1981) J. Biol. Chem. 256,2101–2104.Google Scholar
  24. 24.
    Marcel Y.L. (1982) Adv. Lipid Res. 19,85–135,Google Scholar
  25. 25.
    Tall A.R.(1986)J. Lipid Res. 27, 361–367.PubMedGoogle Scholar
  26. 26.
    Fielding C.J. (1987) Am. Heart J. 113,532–537.PubMedCrossRefGoogle Scholar
  27. 27.
    Glomset J.A. and Norum K.R.(1973) Adv. Lipid Res. I,1–65.Google Scholar
  28. 28.
    Tam S.P. and Breckenridge W.C.(1983)J. Lipid Res. 24,1343–1357.PubMedGoogle Scholar
  29. 29.
    Mahley R.W., Hui D.Y., Innerarity T.L. and Weisgraber K.H.(1981) J. Clin. Invest. 68,1197–1206.PubMedCrossRefGoogle Scholar
  30. 30.
    Milne R.W., Blanchette L., Theolis R., Weech P.K., and Marcel Y.L.(1987) Molec. Immunol. 24,435–447.CrossRefGoogle Scholar
  31. 31.
    Hesler C.B., Tall A.R., Swenson T.L., Weech P.K., Marcel Y.L. and Milne R.W.(1988) J. Biol. Chem. 263,5020–5023.PubMedGoogle Scholar
  32. 32.
    Tall A.R., Forester L.R., and Bongiovanni G.L. (1983) J. Lipid Res. 24,277–289.PubMedGoogle Scholar
  33. 33.
    Cheung M.C., Wolf A.C., Lum K.D., Tollefson S.H., and Albers J.J.(1986)J. Lipid Res. 27,1135–1144.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Y. L. Marcel
    • 2
  • R. W. Milne
    • 2
  • P. K. Weech
    • 2
  • H. Czarnecka
    • 1
  • C. B. Hesler
    • 1
  • A. R. Tall
    • 2
  1. 1.Clinical Research Institute of MontrealMontrealCanada
  2. 2.Department of MedicineColumbia University College of Physicians & SurgeonsUSA

Personalised recommendations